ACCEPT DECLINE
Change Visitor Type Sign up to our newsletter

The Team

Alexander (Sandy) Flockhart CBE

Non-Executive Director

Sandy is a Board Member of Oxford Capital. He contributes broad experience in financial services, management, regulatory affairs and fiduciary responsibility. He is also an independent member of the firm’s Investment Committee.

Sandy is an international banking executive with Board level, M&A and advisory experience around the world.  In December 2007, he received a CBE in recognition of his services to British business and charitable services and financial institutions.  He is a team player who enjoys bringing different views into play and being challenged.  He has expertise in nurturing talent and embracing diversity to achieve extraordinary results.

Sandy had a long career with HSBC Banking Group, a leading global institution. He reached the most senior positions, having been CEO of its largest subsidiary in Asia-Pacific and also its largest subsidiary in Latin America. He was later promoted to Chairman of HSBC UK, the group’s largest European subsidiary and was appointed to the main Board of HSBC Holdings.  Through these roles, Sandy had broad visibility within the investor and analyst community, as well as with regulators in the UK and in other countries.  Since retiring from HSBC Sandy has been chairman of a challenger bank in the UK and was a partner in a private equity firm.

Prior to becoming a banker, Sandy read law at Edinburgh University, taking an LLB. In his spare time he is a keen cyclist, fisherman and golfer on courses around his home near Edinburgh.

  • Curve becomes the first fintech in Europe to sell NFTs in an online auction


    Read more
  • Intelligent Partnership quarterly EIS update – featuring Oxford Capital


    Read more

  • News and Views

    The lastest industry news and views
    from our team at Oxford Capital.

    see more
  • HelloSelf raises £5.5m in Series A fundraising round


    Read more
  • Integrated Review reinforces the Government’s commitment to science and technology – Oxford Capital commentary


    Read more
  • Oxford BioTherapeutics awards Venn Life Sciences with a new contract


    Read more
  • Moneybox launches mortgage advice service


    Read more